المؤلفون: Carolin C. Hack MD, Peter A. Fasching MD, Tanja Fehm MD, Johann de Waal MD, Mahdi Rezai MD, Bernd Baier MD, Gerold Baake MD, Hans-Christian Kolberg MD, Martin Guggenberger MD, Mathias Warm MD, Nadia Harbeck MD, Rachel Wuerstlein MD, Jörg-Uwe Deuker MD, Peter Dall MD, Barbara Richter MD, Grischa Wachsmann MD, Cosima Brucker MD, Jan W. Siebers MD, Nikos Fersis MD, Thomas Kuhn MD, Christopher Wolf MD, Hans-Walter Vollert MD, Georg-Peter Breitbach MD, Wolfgang Janni MD, Robert Landthaler MD, Andreas Kohls MD, Daniela Rezek MD, Thomas Noesslet MD, Gunnar Fischer MD, Stefan Henschen MD, Thomas Praetz MD, Volker Heyl MD, Thorsten Kühn MD, Thomas Krauss MD, Christoph Thomssen MD, Andre Hohn MD, Hans Tesch MD, Christoph Mundhenke MD, Alexander Hein MD, Claudia Rauh MD, Christian M. Bayer MD, Adib Jacob, Katja Schmidt PhD, Erik Belleville PhD, Peyman Hadji MD, Sara Y. Brucker MD, Diethelm Wallwiener MD, Sherko Kümmel MD, Matthias W. Beckmann MD, Daniela Paepke MD

المصدر: Integrative Cancer Therapies
Integrative Cancer Therapies, Vol 16 (2017)

مصطلحات موضوعية: integrative medicine, letrozole, Aromatase Inhibitors, Medizin, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Antineoplastic Agents, Breast Neoplasms, Middle Aged, Triazoles, information, Postmenopause, breast cancer, Germany, oncology, aromatase inhibitor, Nitriles, Humans, Female, therapy management, Prospective Studies, RC254-282, Research Articles, complementary and alternative medicine, Aged

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5d4228953f1d70f81af0512e555ea5b8
http://europepmc.org/articles/PMC5739129